[
    [
        {
            "time": "",
            "orginal_text": "药明康德现2笔大宗交易合计成交13.70万股",
            "features": {
                "keywords": [
                    "药明康德",
                    "大宗交易",
                    "成交"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "药明康德现2笔大宗交易合计成交13.70万股",
            "scores": {
                "News_content": "药明康德现2笔大宗交易合计成交13.70万股",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "穆迪：上调药明康德展望至“正面”。并确认其“Baa3”评级",
            "features": {
                "keywords": [
                    "穆迪",
                    "上调",
                    "药明康德",
                    "正面",
                    "Baa3"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "穆迪：上调药明康德展望至“正面”。并确认其“Baa3”评级",
            "scores": {
                "News_content": "穆迪：上调药明康德展望至“正面”。并确认其“Baa3”评级",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "医药行业周报：胰岛素、精麻药品专项带量采购启动在即",
            "features": {
                "keywords": [
                    "医药行业",
                    "胰岛素",
                    "精麻药品",
                    "带量采购"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "医药行业周报：胰岛素、精麻药品专项带量采购启动在即",
            "scores": {
                "News_content": "医药行业周报：胰岛素、精麻药品专项带量采购启动在即",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "各种“茅”集体重挫！外资仍在扫货，资金流向低估值赛道？",
            "features": {
                "keywords": [
                    "茅",
                    "重挫",
                    "外资",
                    "扫货",
                    "低估值"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "各种“茅”集体重挫！外资仍在扫货，资金流向低估值赛道？",
            "scores": {
                "News_content": "各种“茅”集体重挫！外资仍在扫货，资金流向低估值赛道？",
                "Correlation": 4,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "药明康德今日大宗交易成交13.70万股，成交价129.21元溢价0.0%",
            "features": {
                "keywords": [
                    "药明康德",
                    "大宗交易",
                    "成交",
                    "溢价"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "药明康德今日大宗交易成交13.70万股，成交价129.21元溢价0.0%",
            "scores": {
                "News_content": "药明康德今日大宗交易成交13.70万股，成交价129.21元溢价0.0%",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "因可转换债券获转换药明康德(02359)发行8.84万股",
            "features": {
                "keywords": [
                    "药明康德",
                    "可转换债券",
                    "发行"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "因可转换债券获转换药明康德(02359)发行8.84万股",
            "scores": {
                "News_content": "因可转换债券获转换药明康德(02359)发行8.84万股",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "医药生物行业周报：年报密集披露 关注业绩超预期个股",
            "features": {
                "keywords": [
                    "医药生物",
                    "年报",
                    "业绩",
                    "超预期"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物行业周报：年报密集披露 关注业绩超预期个股",
            "scores": {
                "News_content": "医药生物行业周报：年报密集披露 关注业绩超预期个股",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "收评 | 基金重仓股重挫创业板跌4% 如何应对",
            "features": {
                "keywords": [
                    "基金",
                    "重仓股",
                    "重挫",
                    "创业板",
                    "跌"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "收评 | 基金重仓股重挫创业板跌4% 如何应对",
            "scores": {
                "News_content": "收评 | 基金重仓股重挫创业板跌4% 如何应对",
                "Correlation": 3,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "东吴证券-医药生物行业：医药核心资产，其估值已进入底部区域【行业研究】",
            "features": {
                "keywords": [
                    "东吴证券",
                    "医药生物",
                    "核心资产",
                    "估值",
                    "底部"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "东吴证券-医药生物行业：医药核心资产，其估值已进入底部区域【行业研究】",
            "scores": {
                "News_content": "东吴证券-医药生物行业：医药核心资产，其估值已进入底部区域【行业研究】",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "机构抱团股持续走弱，Wind茅指数跌超3%",
            "features": {
                "keywords": [
                    "机构",
                    "抱团股",
                    "走弱",
                    "Wind茅指数",
                    "跌"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "机构抱团股持续走弱，Wind茅指数跌超3%",
            "scores": {
                "News_content": "机构抱团股持续走弱，Wind茅指数跌超3%",
                "Correlation": 4,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]